ALINARI, LAPO
 Distribuzione geografica
Continente #
NA - Nord America 1.673
EU - Europa 1.220
AS - Asia 597
AF - Africa 88
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.582
Nazione #
US - Stati Uniti d'America 1.664
GB - Regno Unito 361
SE - Svezia 251
CN - Cina 204
SG - Singapore 150
DE - Germania 141
VN - Vietnam 130
IT - Italia 125
UA - Ucraina 84
RU - Federazione Russa 62
IN - India 51
IE - Irlanda 48
FR - Francia 36
HR - Croazia 30
JO - Giordania 26
CI - Costa d'Avorio 24
ZA - Sudafrica 24
TG - Togo 21
CH - Svizzera 19
EE - Estonia 17
BE - Belgio 13
FI - Finlandia 12
JP - Giappone 11
IR - Iran 10
NG - Nigeria 10
BG - Bulgaria 7
CA - Canada 6
ES - Italia 5
SC - Seychelles 5
TN - Tunisia 4
GR - Grecia 3
HK - Hong Kong 3
MX - Messico 3
TR - Turchia 3
TW - Taiwan 3
LB - Libano 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ID - Indonesia 1
IQ - Iraq 1
MY - Malesia 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 3.582
Città #
Southend 316
Chandler 178
Fairfield 175
Ann Arbor 155
Singapore 123
Ashburn 107
Woodbridge 104
Seattle 100
Houston 96
Wilmington 87
Cambridge 80
Jacksonville 60
Princeton 56
Santa Clara 53
Dublin 48
Boardman 42
Nanjing 34
Dong Ket 33
Padova 27
Turin 27
Westminster 27
Amman 26
Abidjan 24
New York 23
Beijing 21
Lomé 21
Berlin 20
Saint Petersburg 15
Bern 14
Los Angeles 14
Jinan 13
Bologna 12
Helsinki 12
Redwood City 12
Shenyang 12
Brussels 11
Nanchang 11
Abeokuta 10
Florence 10
Tokyo 10
Bremen 9
Milan 9
Mülheim 9
San Diego 9
Zhengzhou 9
Jiaxing 8
Changsha 7
Sofia 7
Falkenstein 6
Hebei 6
Zanjan 6
Dearborn 5
Ningbo 5
Norwalk 5
Tianjin 5
Kunming 4
Lausanne 4
Mahé 4
Taizhou 4
Wuhan 4
Falls Church 3
Gallarate 3
Guangzhou 3
Istanbul 3
London 3
Madrid 3
Mexico 3
Shenzhen 3
Taipei City 3
Taiyuan 3
Verona 3
Winnipeg 3
Andover 2
Barcelona 2
Buffalo 2
Fremont 2
Haikou 2
Hamm 2
Hangzhou 2
Hong Kong 2
Jinhua 2
Leawood 2
Mechelen 2
Monmouth Junction 2
Moscow 2
Munich 2
Olalla 2
Phoenix 2
Sacramento 2
Wayne 2
Yubileyny 2
Auckland 1
Baghdad 1
Baoding 1
Brindisi 1
Büdelsdorf 1
Carol Stream 1
Catalão 1
Changzhou 1
Chicago 1
Totale 2.427
Nome #
18F-FDG PET early after radiotherapy in lymphoma patients. 240
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. 186
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. 176
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. 170
18 F-FDG PET in malignant lymphoma: significance of positive findings 168
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience 150
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. 148
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 139
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma. 138
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 137
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. 133
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 127
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma. 127
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. 125
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. 125
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. 125
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma. 125
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 122
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. 121
Discordant response to chemotherapy: An unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients 117
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. 116
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma. 113
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. 110
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 99
Rituximab in primary conjunctiva lymphoma. 97
FDG-PET in the serial assessment of patinets with lymphoma in complete remission 93
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine 90
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 28
Totale 3.645
Categoria #
all - tutte 9.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020374 0 0 0 0 0 0 0 125 112 53 40 44
2020/2021486 93 32 8 22 17 90 12 37 33 30 37 75
2021/2022717 156 16 56 97 42 28 14 41 15 39 139 74
2022/2023736 84 88 46 87 57 59 12 32 157 21 58 35
2023/2024150 7 32 9 20 12 41 6 5 3 10 3 2
2024/2025387 10 112 45 41 108 39 31 1 0 0 0 0
Totale 3.645